Our Mission
Five Rivers RX promotes the quality, security and integrity of the pharmaceutical supply chain through consulting and administrative solutions that leverage innovation, expertise, and technology. We are hyper-focused on client care and meeting client objectives.
Ready To Schedule A Free Consultation?
Our Compliance Expertise
The Importance of State Compliance
Navigating the intricacies of state licensing can be challenging and often lead to businesses wasting valuable time and money. Keeping track of each individual state’s requirements proves difficult but is essential to remain in good standing with each Board of Pharmacy. Many companies often fall down a rabbit hole trying to solve their own compliance needs, and as a result, business growth is stunted.
Five Rivers RX offers our expertise to eliminate any loss of productivity or money, as well as in fostering the legitimacy of your company’s operations. Entrusting us with your compliance maintenance allows you to focus on the growth of your business, uninterrupted.
Innovative Approach with Best-In-Class Service
We have the necessary tools and expertise to help you properly manage your expansion or your next project. Through a dynamic partnership with our clients, we develop engaging business strategies and high quality, scalable solutions.
We provide comprehensive solutions that promote quality and security in the pharmaceutical supply chain. Our services span federal and state requirements including state licensing, VAWD accreditation, DEA compliance, and more.
Innovative Approach with Best-In-Class Service
We have the necessary tools and expertise to help you properly manage your expansion or your next project. Through a dynamic partnership with our clients, we develop engaging business strategies and high quality, scalable solutions.
We provide comprehensive solutions that promote quality and security in the pharmaceutical supply chain. Our services span federal and state requirements including state licensing, VAWD accreditation, DEA compliance, and more.
Industry News
Proposed Rules for DEA Suspicious Orders
In November 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) proposing to revise its regulations relating to suspicious orders of controlled substances. The proposed rules will clarify requirements to process a suspicious...
Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
Last month, Iowa became the second of five states to formally recognize/approve the NCDQS QAS Accreditation program, and the first state to approve the program by rule, revising Iowa Code section 17A.8(6). The Maryland Board of Pharmacy approved the NCDQS QAS...
NavigateSOM Releases User Manual
NavigateSOM is excited to announce the release of our User Manual. Our goal is to walk clients through step by step how to most effectively utilize every feature in their portal, giving them the most value. It begins with gaining access to your portal and some helpful...
